Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.530
+0.200 (15.04%)
At close: Jun 27, 2025, 4:00 PM
1.540
+0.010 (0.65%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,873,720
Market Cap
17.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CTXR News
- 11 days ago - Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PRNewsWire
- 16 days ago - Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 18 days ago - Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 7 weeks ago - Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 3 months ago - Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - PRNewsWire
- 4 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 5 months ago - Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services - PRNewsWire